Skip to main content
. 2012 May 29;3:108. doi: 10.3389/fpls.2012.00108

Figure 4.

Figure 4

Effect of T. hamatum T382 treatment on suppression of B. cinerea disease in A. thaliana mutants (npr1, sid2, myc2, etr1, ein2, tt, chs, f3h, rbohD, vtc1) or transformants (NahG), affected in different disease-related pathways. Affected pathways are indicated below the mutant name. Quantitative analysis of the ISR-effect of T. hamatum T382 (T) against B. cinerea infection. Comparison of disease symptoms, calculated as average lesion diameters and measured on 2, 3, and 4 days post-inoculation (dpBi) with B. cinerea of mock-treated wild-type (blue) or mutant plants (red) and of T. hamatum T382 treated wild-type (dark green) and mutant plants (light green). Disease assays were repeated four to six times comprising a total of 100–250 plants depending on the mutant used. Confidence intervals (95%) are shown.